The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAutins Group Regulatory News (AUTG)

Share Price Information for Autins Group (AUTG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.00
Ask: 12.00
Change: 0.00 (0.00%)
Spread: 2.00 (20.00%)
Open: 11.00
High: 11.00
Low: 11.00
Prev. Close: 11.00
AUTG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full-Year Trading Update

20 Oct 2023 07:00

RNS Number : 7275Q
Autins Group PLC
20 October 2023
 

 

20 October 2023

Autins Group plc

("Autins" the "Company" or the "Group")

 

Full-Year Trading Update

 

Autins Group plc (AIM: AUTG), the UK and European based manufacturer of the patented Neptune melt-blown material and specialist in the design, manufacture, and supply of acoustic and thermal insulation solutions, provides a trading update for the year ended 30 September 2023.

 

The unaudited results for FY23 show Group sales increased by 20% to £22.5m (FY22: £18.8m). Sales in H2 23 continued to gain momentum, increasing by 7.5% to £11.7m (H1 23: £10.8m). Gross Profit in the year improved by c.55% to c.£6.5m (FY22: £4.2m) driven by the increase in revenue and a strong recovery in Gross Margins of 6.5 ppts to 28.9% (FY22 22.4%). The Group also continued to successfully control overheads and EBITDA (stated on an IFRS 16 Basis) is expected to improve by £2.1m to £1.0m (FY22: loss of £1.1m).

 

The Group ended the period with net debt (being the net of cash and cash equivalents and the Group's loans and borrowings, excluding right of use lease liabilities) of c.£1.8m (FY22 £2.0m).  Cash and cash equivalents available to the Group were £2.1m (FY22 £1.8m). The Board believes that the improvement in its trading performance and the stability of its net debt and headroom level will put the Group in a positive position when engaging with its lending partners regarding covenants for March 2024 onwards. 

 

The Group has continued to win new business in the latter part of the year including thermal applications in electric vehicles. Our Neptune technology provides a significant performance advantage in reducing the thermal losses in electric vehicles and thereby reducing the draw down of energy from electric batteries which helps to extend vehicle range. The Company has also launched a 100% fully recyclable version of Neptune which has received very good interest from OEMs as they strive to have more recyclable content in future vehicles.

 

The Board expects a continued recovery in the Automotive market and therefore anticipates further growth in sales and EBITDA in FY24.

 

For further information please contact:

Autins Group plc

Gareth Kaminski-Cook, Chief Executive

Kamran Munir, CFO

 

 

Via SEC Newgate

Singer Capital Markets

(Nominated Adviser and Broker)

James Moat / Asha Chotai

 

Tel: 020 7496 3000

SEC Newgate

(Financial PR)

Bob Huxford / Molly Richardson

 

 

Tel: 020 7653 9850

 

About Autins

Autins is a UK and continental Europe based industrial materials technology business that specialises in the design, manufacture, and supply of acoustic and thermal products. Its key markets are automotive, flooring, office furniture and commercial vehicles where it supplies products and services to more than 160 customer locations across Europe.

Autins is the UK and European manufacturer of the patented Neptune melt-blown material and specialises in the design, manufacture, and supply of acoustic and thermal insulation solutions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMLBFTMTBBBLJ
Date   Source Headline
10th Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20242:52 pmRNSResult of AGM
6th Mar 20244:46 pmRNSHolding(s) in Company
6th Mar 20244:40 pmRNSHolding(s) in Company
4th Mar 20247:03 amRNSNotice of AGM
4th Mar 20247:02 amRNSFull Year Results
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Nov 20237:00 amRNSAppointment of Non-Executive Director
20th Oct 20237:00 amRNSFull-Year Trading Update
27th Jun 20237:00 amRNSInterim Results
15th May 20237:00 amRNSAppointment of Non-Executive Director
11th Apr 202310:20 amRNSHolding(s) in Company
28th Mar 20232:12 pmRNSResult of Annual General Meeting
22nd Feb 20237:00 amRNSPublication of Report & Accounts and Notice of AGM
31st Jan 20237:00 amRNSFull Year Results
17th Jan 20237:00 amRNSHolding(s) in Company
13th Dec 20224:37 pmRNSHolding(s) in Company
21st Oct 202210:33 amRNSHolding(s) in Company
10th Oct 20227:00 amRNSTrading Update
28th Jun 20227:00 amRNSInterim Results
9th Jun 20227:00 amRNSChange of Auditor
17th Mar 20223:44 pmRNSResult of AGM
17th Mar 20227:00 amRNSAGM Statement
21st Feb 20225:45 pmRNSNotice of AGM
28th Jan 20221:55 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSFull Year Results
9th Dec 20212:27 pmRNSResult of General Meeting
19th Nov 20215:47 pmRNSClose of Bookbuild and Result of Placing
19th Nov 20213:33 pmRNSProposed Placing to raise £3.0m & Notice of GM
11th Oct 202111:02 amRNSHolding(s) in Company
11th Oct 20217:30 amRNSInvestment in Autins Group plc
30th Jun 20217:00 amRNSInterim Results
12th Mar 202112:08 pmRNSResult of AGM
16th Feb 20217:01 amRNSDirectorate Change
16th Feb 20217:00 amRNSNotice of AGM
20th Jan 20217:05 amRNSManagement Long Term Incentive Plan
20th Jan 20217:00 amRNSFinal Results
27th Jul 202012:09 pmRNSHolding(s) in Company
24th Jul 20202:49 pmRNSHolding(s) in Company
23rd Jul 20207:00 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSHolding(s) in Company
8th Jul 202011:28 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSCompletion of CBILs Funding
29th Jun 20207:00 amRNSInterim Results
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSTrading and COVID-19 Update
12th Feb 202011:09 amRNSHolding(s) in Company
12th Feb 202010:25 amRNSHolding(s) in Company
7th Feb 202012:25 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.